To understand the cellular and molecular mechanisms involved in regulation of physiological and pathological bone resorption, there is a critical need to develop a marker that identifies osteoclasts and permits distinction of these cells from hematopoietic precursors and other multinucleated giant cells (e.g. foreign body giant cells). To fulfill this need, we have cloned cDNAs that encode high affinity receptors for calcitonin (CT), the principal peptide hormone that regulates the functional activity of osteoclasts. The goal of this application is to exploit our knowledge of the structure of the human CT receptor (CTR) and the availability of molecular probes to answer the following questions: I. What are the structural and functional properties of the osteoclast CTR? RNA prepared from human giant cell tumors of bone and the reverse transcriptase/polymerase chain reaction (RT-PCR) and cloning techniques will be utilized to sequence and characterize the structural and functional properties of the human osteoclast-type CTR. 2. What is the phenotypic relationship between bone resorbing cells in physiological and pathological remodeling? Are there osteoclast """"""""subtypes"""""""" without CTRs and what controls their development? In situ hybridization techniques and immunohistochemistry with antibodies to the human CTR will be used to demonstrate the distribution and specific cell-types expressing the CTR. Characterization and comparison of cells in specific bone lesions, e.g. Paget's disease of bone and other forms of granulomatous lesions in which the phenotype of the giant cells and their relationship to osteoclasts is not well understood will be undertaken. Examination of bone samples from individuals with refractoriness to CT will provide insights into the mechanisms by which CTR expression is regulated in these conditions. 3. What are the cellular and molecular mechanisms regulating CTR gene expression during osteoclast differentiation? We propose to clone and characterize the human CTR gene. To define the specific and potentially unique regulatory sequences responsible for expression of the CTR, constructs of the CTR 5' region containing the putative promoter regions of the CTR gene will be linked to a chloramphenicol transferase (CAT) reporter gene and screened for the capacity of specific hormones or cytokines to induce CTR expression using transfection in human mononuclear cell lines. This system can then be used to identify potentially unique factors that have the capacity to regulate CTR gene expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK046773-02
Application #
2146022
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1994-05-01
Project End
1998-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Thammasitboon, Kewalin; Goldring, Steven R; Boch, Jason A (2006) Role of macrophages in LPS-induced osteoblast and PDL cell apoptosis. Bone 38:845-52
Goldring, Steven R; Goldring, Mary B (2004) The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res :S27-36
Gonsky, Rivkah; Deem, Richard L; Bream, Jay et al. (2004) Enhancer role of STAT5 in CD2 activation of IFN-gamma gene expression. J Immunol 173:6241-7
Ghalambor, Navid; Cho, David R; Goldring, Steven R et al. (2002) Microscopic metallic wear and tissue response in failed titanium hallux metatarsophalangeal implants: two cases. Foot Ankle Int 23:158-62
Anusaksathien, O; Laplace, C; Li, X et al. (2001) Tissue-specific and ubiquitous promoters direct the expression of alternatively spliced transcripts from the calcitonin receptor gene. J Biol Chem 276:22663-74
Pettit, A R; Ji, H; von Stechow, D et al. (2001) TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 159:1689-99
Goldring, S R; Gravallese, E M (2000) Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 12:195-9
Gravallese, E M; Manning, C; Tsay, A et al. (2000) Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43:250-8
Inoue, D; Shih, C; Galson, D L et al. (1999) Calcitonin-dependent down-regulation of the mouse C1a calcitonin receptor in cells of the osteoclast lineage involves a transcriptional mechanism. Endocrinology 140:1060-8
Pogrel, M A; Regezi, J A; Harris, S T et al. (1999) Calcitonin treatment for central giant cell granulomas of the mandible: report of two cases. J Oral Maxillofac Surg 57:848-53

Showing the most recent 10 out of 18 publications